Mirum Pharmaceuticals, Inc.
MIRM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $282 | $228 | $212 | $223 |
| Short-Term Investments | $94 | $76 | $66 | $58 |
| Receivables | $107 | $107 | $96 | $78 |
| Inventory | $24 | $23 | $22 | $22 |
| Other Curr. Assets | $24 | $19 | $15 | $12 |
| Total Curr. Assets | $531 | $453 | $411 | $393 |
| Property Plant & Equip (Net) | $10 | $10 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $232 | $238 | $244 | $250 |
| Long-Term Investments | $2 | $17 | $21 | $13 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $7 | $6 | $6 |
| Total NC Assets | $255 | $272 | $279 | $278 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $785 | $726 | $690 | $671 |
| Liabilities | – | – | – | – |
| Payables | $12 | $18 | $12 | $15 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $146 | $125 | $114 | $110 |
| Total Curr. Liab. | $160 | $145 | $128 | $127 |
| LT Debt | $317 | $317 | $316 | $316 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $16 | $9 | $14 | $3 |
| Total NC Liab. | $333 | $326 | $329 | $319 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $10 | $9 | $10 |
| Total Liabilities | $493 | $471 | $457 | $445 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$662 | -$665 | -$659 | -$644 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $954 | $920 | $892 | $870 |
| Total Equity | $292 | $255 | $233 | $226 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $785 | $726 | $690 | $671 |
| Net Debt | $37 | $91 | $105 | $95 |